Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX)

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
20,907,188
Total 13F shares
598,063
Share change
+137,070
Total reported value
$176,258,559
Price per share
$294.74
Number of holders
11
Value change
+$40,385,596
Number of buys
9
Number of sells
2

Institutional Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q4 2025

As of 31 Dec 2025, Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 598,063 shares. The largest 10 holders included Assenagon Asset Management S.A., Aberdeen Group plc, CONGRESS ASSET MANAGEMENT CO, SG Americas Securities, LLC, NISA INVESTMENT ADVISORS, LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Allspring Global Investments Holdings, LLC, GAMMA Investing LLC, ORG Partners LLC, and Marquette Asset Management, LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.